Most Participants in an Oral-THC Study Used Their Oil Sublingually
A study described as oral cannabis research reported that most participants administered their oil sublingually. The route label should be read alongside the actual administration procedure.
The methods retained patients’ prescribed practice
In the oil sample, thirty-eight of forty-one participants used a sublingual method, while three used oral administration as classified by the paper. Products and cannabinoid amounts varied. The study therefore did not represent one standardized swallowed preparation used in an identical way by everyone.
Route categories do not define absorption precisely
Holding an oil under the tongue can differ from immediately swallowing a capsule, but the label alone does not quantify how much entered through oral mucosa or was swallowed. The investigators did not establish that fraction for every participant. The appropriate description preserves the reported behavior without assigning an unmeasured absorption pathway.
Comparison with edibles needs care
A finding from this oil protocol cannot automatically establish the effects or time course of a gummy, capsule or other edible. Product vehicle, administration and dose all matter. This does not invalidate the cognitive study; it identifies which real-world practices the results describe. When applying a paper, report what participants actually did rather than allowing a broad oral label to imply an identical procedure across every formulation.
Related analysis: the study’s main findings and limitations.
Research cited
Stefanidis and colleagues. Elucidating the acute effects of medically prescribed oral and vaporised delta-9-tetrahydrocannabinol on cognitive functions important for driving. Drug and Alcohol Review (2025). DOI: 10.1111/dar.14060.
